Literature DB >> 12458775

Epoxyquinol B, a fungal metabolite with a potent antiangiogenic activity.

Hideaki Kakeya, Rie Onose, Arika Yoshida, Hiroyuki Koshino, Hiroyuki Osada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12458775     DOI： 10.7164/antibiotics.55.829

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  RQN-18690A (18-deoxyherboxidiene) targets SF3b, a spliceosome component, and inhibits angiogenesis.

Authors:  Hideaki Kakeya; Daisuke Kaida; Hiromi Sekiya; Koji Nagai; Minoru Yoshida; Hiroyuki Osada
Journal:  J Antibiot (Tokyo)       Date:  2015-09-09       Impact factor: 2.649

Review 2.  Toward a Cancer Drug of Fungal Origin.

Authors:  Alexander Kornienko; Antonio Evidente; Maurizio Vurro; Véronique Mathieu; Alessio Cimmino; Marco Evidente; Willem A L van Otterlo; Ramesh Dasari; Florence Lefranc; Robert Kiss
Journal:  Med Res Rev       Date:  2015-04-08       Impact factor: 12.944

3.  Iron salt-promoted oxidation of steroidal phenols by m-chloroperbenzoic acid: a route to possible antitumor agents.

Authors:  Tatjana J Kop; Nataša Terzić-Jovanović; Željko Žižak; Bogdan A Šolaja; Dragana R Milić
Journal:  RSC Adv       Date:  2022-07-18       Impact factor: 4.036

4.  Azaspirene, a fungal product, inhibits angiogenesis by blocking Raf-1 activation.

Authors:  Yukihiro Asami; Hideaki Kakeya; Yusuke Komi; Soichi Kojima; Kiyohiro Nishikawa; Kristin Beebe; Len Neckers; Hiroyuki Osada
Journal:  Cancer Sci       Date:  2008-07-10       Impact factor: 6.716

5.  Two cyclic hexapeptides from Penicillium sp. FN070315 with antiangiogenic activities.

Authors:  Jun-Pil Jang; Hye Jin Jung; Jang Mi Han; Narae Jung; Yonghyo Kim; Ho Jeong Kwon; Sung-Kyun Ko; Nak-Kyun Soung; Jae-Hyuk Jang; Jong Seog Ahn
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.